Revista de Osteoporosis y Metabolismo Mineral

Empresas Colaboradoras:

The Journal follows the Uniform Requirements standards Manuscripts Submitted to Biomedical for Journals www.icmje.org

The Journal embraces the principles and procedures dictated by the Committee on Publication Ethics (COPE) www.publicationethics.org

Visits since 2015
AmazingCounters.com

 

Author: Romm

Background history of Revista de Osteoporosis y Metabolismo Mineral. The situation ten years on

(  PDF )   Rev Osteoporos Metab Miner. 2018; 10 (1): 3-6 DOI: 10.4321/S1889-836X2018000100001 Sosa Henríquez M1,2,3, Gómez de Tejada Romero MJ2,4,5 1 Director de Revista de Osteoporosis y Metabolismo Mineral 2 Instituto Universitario de Investigaciones Biomédicas y Sanitarias – Universidad de Las Palmas de Gran Canaria – Grupo de investigación en osteoporosis y metabolismo mineral – Las Palmas de Gran Canaria (España) 3 Unidad Metabólica Ósea – Hospital Universitario Insular – Las Palmas de Gran Canaria (España) 4 Redactora de Revista de Osteoporosis y Metabolismo Mineral 5 Departamento de Medicina – Universidad de Sevilla – Sevilla (España)   As we prepare to mark our journal’s 10th anniversary, we would like to retrace our steps along the journey so far and describe the current situation for our readers’ knowledge. The Journal’s beginnings and its raison d’être  The journal Revista de Osteoporosis y Metabolismo Mineral (ROMM) is the scientific publication of the Spanish Society of Bone Research and Mineral Metabolism (SEIOMM, from its original Spanish title). Its creation was agreed on during the XIII SEIOMM Congress held in Oviedo in 2008. Until then, the Society journal was the Spanish Journal of Bone Metabolic Diseases, which had been founded in 1993 by Dr. Aurelio Rapado Errazti and presented at the SEIOMM Congress held in Córdoba, Spain. Known as REEMO, this belonged to the Elsevier publishing company, then Doyma, directed by Dr. Rapado. This journal had...

Read More

Vitamin D deficiency in postmenopausal Ecuadorian women with diabetes mellitus type 2

(  PDF )   Rev Osteoporos Metab Miner. 2018; 10 (1): 7-14 DOI: 10.4321/S1889-836X2018000100002 López Gavilanez E1, Orces CH2, Guerrero Franco K3, Segale Bajaña Á3, Veliz Ortega J3, Bajaña Granja W4 1 Servicio de Endocrinología – Hospital Docente Policía Nacional – Guayaquil (Ecuador) 2 Centro Médico de Laredo – Laredo – Texas (Estados Unidos) 3 Servicio de Medicina Interna – Hospital Docente Policía Nacional – Guayaquil (Ecuador) 4 Laboratorio Clínico Interlab – Guayaquil (Ecuador)   Summary Objectives: To know the prevalence of vitamin D insufficiency in Ecuadorian postmenopausal women with type 2 diabetes mellitus, and to investigate the correlation between serum levels of vitamin D, variables of metabolic control of type 2 diabetes mellitus, markers of bone metabolism and bone mineral density. Design, materials and methods: Epidemiological study descriptive and cross-sectional design, carried out between January 2012 November 2015. In 124 postmenopausal women, 96 with type 2 diabetes mellitus and 28 without diabetes, we measured serum levels of vitamin D, glycosylated hemoglobin, HOMA-IR, parathyroid hormone, ionic calcium, osteocalcin, urinary deoxypiridinoline and bone density. Premenopausal women, kidney disease, type 1 diabetes, secondary osteoporosis, and those who received treatments that affect bone metabolism, were excluded. We separate patients with type 2 diabetes mellitus in 2 groups: group sufficiency vitamin D (>30 ng/mL) and group insufficiency vitamin D (<30 ng/mL). The latter group was subdivided into insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10...

Read More

Relationship between the presence of anemia and the risk of osteoporosis in women with rheumatoid arthritis

(  PDF )   Rev Osteoporos Metab Miner. 2018; 10 (1): 15-20 DOI: 10.4321/S1889-836X2018000100003 Batún-Garrido JAJ1, Salas-Magaña M2 1 Servicio Medicina Interna – Centro Médico ISSET (Instituto de Seguridad Social del Estado de Tabasco) – Villahermosa – Tabasco (México) 2 Departamento de Ciencias Biomédicas – Universidad Juárez Autónoma de Tabasco – Villahermosa – Tabasco (México)   Summary Introduction: Patients with rheumatoid arthritis present a high prevalence of osteoporosis, partly due to the use of glucocorticoids. However, there are other causal factors. Material and methods: 122 women diagnosed with rheumatoid arthritis were studied. Serum hemoglobin concentrations were determined and bone densitometry carried out by dual energy X-ray absorptiometry. A multivariate logistic regression model was used to determine the association of the variables studied. Results: 32.8% of the women studied presented hemoglobin <12 g/dL. The mean T-score in the lumbar spine was -1.8±1.5; 36.9% had a low bone mass, 32.8% osteoporosis criteria and 30.3% normal T-score. The mean of the femur T-score was -0.6±1.4; 63.9% was normal value, 23.8% presented low bone mass and 12.3% criterion of osteoporosis. Hemoglobin ≥12 g/dL and a bone mineral density (BMD) of the normal femur (p=0.003), and between hemoglobin <12 g/dL and BMD of femur with osteoporosis (p<0.000). There was an independent association between osteoporosis and body mass index <30 kg/m2 (OR=4.1, 95% CI: 1.4-11.4, p=0.009) and the presence of anemia (OR=8.9, 95% CI: 3.7-22.4, p=0.001). Conclusions: In our...

Read More

Effect of biological therapy on concentrations of DKK1 and sclerostin, cardiovascular risk and bone metabolism in patients with rheumatoid arthritis

(  PDF )   Rev Osteoporos Metab Miner. 2018; 10 (1): 21-29 DOI: 10.4321/S1889-836X2018000100004 Palma-Sánchez D1, Haro-Martínez AC1, Gallardo Muñoz I2, Portero de la Torre M2, García-Fontana B3, Reyes-García R4 1 Unidad de Reumatología. Hospital General Universitario Rafael Méndez. Lorca. Murcia (España) 2 Servicio de Radiología. Hospital General Universitario Rafael Méndez. Lorca. Murcia (España) 3 Instituto de Investigación Biosanitaria de Granada. Complejo Hospitalario Universitario de Granada. Granada (España) 4 Servicio de Endocrinología. Hospital Torrecárdenas. Almería (España)   Summary Introduction: Previous studies have linked the Wnt pathway in the alteration of bone metabolism and cardiovascular pathology. Also, the control of inflammation with biological therapy has a positive effect on bone mineral density (BMD) and cardiovascular risk. The aim of the study was to evaluate the effect of biological therapy in patients with rheumatoid arthritis, naïve to these therapy, on the inflammatory load and its relation with cardiovascular risk and bone metabolism. Patients and methods: Prospective cohort study performed in patients diagnosed with active rheumatoid arthritis (RA) initiating biological therapy. Patients were selected consecutively not selected. The serum concentrations of Dickkopf-1 protein (DKK1) and sclerostin were collected, both by means of the ELISA method (Biomedica Medizinprodukte GmbH and Co. KG, Vienna, Austria); demographic and clinical variables, markers of bone remodeling, hip and lumbar spine BMDs were measured by dual energy X-ray absorptiometry (DXA), measurement of intima-media thickness (IMT), evaluation cardiovascular risk by Systematic Coronary Risk...

Read More

Prevention and early diagnosis of childhood osteoporosis: are we doing the right thing?

(  PDF )   Rev Osteoporos Metab Miner. 2018; 10 (1): 30-36 DOI: 10.4321/S1889-836X2018000100005 Mir-Perelló C1, Galindo Zavala R2, González Fernández MI3, Graña Gil J4, Sevilla Pérez B5, Magallares López B6, Bou Torrent R7. (En representación del Grupo de Trabajo en Osteoporosis Infantil y Osteogénesis Imperfecta de la Sociedad Española de Reumatología Pediátrica) 1 Unidad de Reumatología Pediátrica – Servicio de Pediatría – Hospital Universitario Son Espases – Palma de Mallorca (España). Grupo de Investigación en Litiasis Renal y Biomineralización – Instituto de Investigación Sanitaria de la Universidad de las Islas Baleares (IUNICS) – Palma de Mallorca (España) 2 Sección de Reumatología Pediátrica – Unidad de Gestión Clínica de Pediatría – Hospital Regional Universitario de Málaga – Málaga (España). Departamento de Pediatría y Farmacología – Facultad de Medicina – Universidad de Málaga – Málaga (España) 3 Unidad de Reumatología Pediátrica – Hospital Universitario y Politécnico La Fe – Valencia (España) 4 Servicio de Reumatología – Estructura Organizativa de Gestión Integrada (EOXI) – Complejo Hospitalario Universitario de A Coruña – A Coruña (España) 5 Unidad de Gestión Clínica de Pediatría – Hospital Universitario San Cecilio – Granada (España) 6 Servicio de Reumatología – Hospital Santa Creu i Sant Pau – Barcelona (España) 7 Unidad de Reumatología Pediátrica – Hospital Sant Joan de Déu – Esplugues de Llobregat – Barcelona (España)   Summary Objectives: To assess prevention, early diagnosis and training received regarding osteoporosis among...

Read More